MedPath
HSA Approval

Apo-Clopidogrel 75mg Tablet

SIN13571P

Apo-Clopidogrel 75mg Tablet

Apo-Clopidogrel 75mg Tablet

November 13, 2008

PHARMAFORTE SINGAPORE PTE LTD

PHARMAFORTE SINGAPORE PTE LTD

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantPHARMAFORTE SINGAPORE PTE LTD
Licence HolderPHARMAFORTE SINGAPORE PTE LTD

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification

Formulation Information

TABLET, FILM COATED

ORAL

Medical Information

B01AC04

clopidogrel

Manufacturer Information

PHARMAFORTE SINGAPORE PTE LTD

Apotex Inc.

Active Ingredients

Clopidogrel bisulphate 98.0 mg eqv. clopidogrel

75.0 mg

Clopidogrel

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Apo-Clopidogrel 75mg Tablet - HSA Approval | MedPath